Recently, in a phase I placebo-controlled trial conducted by King's College London, Psilocybin was found to be well-tolerated when administered to healthy adult volunteers, and had no negative effects on cognitive and emotional functioning.
from RTT - Biotech https://ift.tt/2rWOhdM
via IFTTT
No comments:
Post a Comment